Health: Clinical Trials News

Today is March 19, 2024. All times in Eastern Daylight Time.

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

03/18/2024 - 05:24 PM

BUSINESS WIRE
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates

03/18/2024 - 04:14 PM

BUSINESS WIRE
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results

03/18/2024 - 04:05 PM

BUSINESS WIRE
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights

03/18/2024 - 04:02 PM

BUSINESS WIRE
Immunis Chairman Dr. Hans Keirstead to Present Abundance360 Moonshot

03/18/2024 - 03:32 PM

BUSINESS WIRE
New Research Shows the PrecivityAD2™ Blood Test Has High Accuracy Compared to Amyloid PET Scans in Individuals with Cognitive Impairment

03/18/2024 - 12:33 PM

BUSINESS WIRE
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion

03/18/2024 - 09:52 AM

BUSINESS WIRE
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

03/18/2024 - 09:05 AM

BUSINESS WIRE
GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study

03/18/2024 - 09:00 AM

BUSINESS WIRE
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio

03/18/2024 - 08:44 AM

BUSINESS WIRE
Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS® T-cell Therapy

03/18/2024 - 08:02 AM

BUSINESS WIRE
Otsuka and Lundbeck Present New Data Analyses on the Efficacy of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer’s Disease

03/18/2024 - 08:00 AM

BUSINESS WIRE
AliveGen Announces Successful Completion of Phase 1b Multiple-Ascending Dose Clinical Trial for ALG-801

03/18/2024 - 08:00 AM

BUSINESS WIRE
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion

03/18/2024 - 07:00 AM

BUSINESS WIRE
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer

03/18/2024 - 07:00 AM

BUSINESS WIRE
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights

03/18/2024 - 07:00 AM

BUSINESS WIRE
KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas

03/18/2024 - 06:30 AM

BUSINESS WIRE
Shaperon Enrolls Its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel'

03/18/2024 - 02:00 AM

BUSINESS WIRE
BeiGene、化学療法後の進行性または転移性食道扁平上皮癌の治療のためのTEVIMBRA®のFDA承認取得

03/16/2024 - 11:18 AM

BUSINESS WIRE
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer

03/16/2024 - 08:00 AM

BUSINESS WIRE
百濟神州喜獲FDA批准，TEVIMBRA®將用於晚期或轉移性食管鱗狀細胞癌在化療後的治療

03/15/2024 - 05:13 PM

BUSINESS WIRE
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

03/15/2024 - 04:15 PM

BUSINESS WIRE
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results

03/15/2024 - 04:05 PM

BUSINESS WIRE
BeiGene recebe aprovação da FDA para TEVIMBRA® para tratamento de câncer espinocelular de esôfago avançado ou metastático após quimioterapia prévia

03/15/2024 - 04:02 PM

BUSINESS WIRE
BeiGene reçoit l'approbation de la FDA pour TEVIMBRA® dans le traitement du carcinome épidermoïde de l’œsophage avancé ou métastatique après une chimiothérapie

03/15/2024 - 04:02 PM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10 11 ... 29

Next »

Search